135 related articles for article (PubMed ID: 33014805)
1. A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection.
He C; Sun S; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():1564. PubMed ID: 33014805
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection.
Tong J; Jiang W; Mao S; Wu S; Lu C
Front Oncol; 2022; 12():1040411. PubMed ID: 36479089
[TBL] [Abstract][Full Text] [Related]
3. A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection.
He C; Huang X; Zhang Y; Cai Z; Lin X; Li S
Front Oncol; 2019; 9():1197. PubMed ID: 31781499
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study.
He C; Zhong L; Zhang Y; Cai Z; Lin X
Cancer Manag Res; 2019; 11():3981-3991. PubMed ID: 31118811
[No Abstract] [Full Text] [Related]
5. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma.
Ren H; Wu CR; Aimaiti S; Wang CF
Oncol Lett; 2020 Jun; 19(6):4093-4105. PubMed ID: 32382348
[TBL] [Abstract][Full Text] [Related]
6. Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment.
He C; Sun S; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():590. PubMed ID: 32426278
[TBL] [Abstract][Full Text] [Related]
7. A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection.
Leng C; Cui Y; Chen J; Wang K; Yang H; Wen J; Fu J; Liu Q
Front Oncol; 2022; 12():925685. PubMed ID: 35875105
[TBL] [Abstract][Full Text] [Related]
8. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
9. A Simple Model Established by Blood Markers Predicting Overall Survival After Radical Resection of Pancreatic Ductal Adenocarcinoma.
Zhang LX; Chen L; Xu AM
Front Oncol; 2020; 10():583. PubMed ID: 32426277
[No Abstract] [Full Text] [Related]
10. Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.
Zhuang H; Zhou Z; Ma Z; Huang S; Gong Y; Li Z; Liu C; Wang S; Chen B; Zhang C; Hou B
Clin Med Insights Oncol; 2021; 15():11795549211024149. PubMed ID: 34211308
[TBL] [Abstract][Full Text] [Related]
11. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: A multicenter study.
Zhang XP; Gao YX; Xu S; Zhao GD; Hu MG; Tan XL; Zhao ZM; Liu R
Int J Surg; 2022 Oct; 106():106891. PubMed ID: 36165934
[TBL] [Abstract][Full Text] [Related]
12. Nomogram and competing risk model to predict recurrence after curative surgical resection of PDAC.
Ge JC; Tao M; Li L; Ma ZL; Jiang B; Yuan CH; Wang HY; Peng Y; Xiu DR
Pancreatology; 2021 May; ():. PubMed ID: 34001437
[TBL] [Abstract][Full Text] [Related]
13. Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.
Pu N; Gao S; Xu Y; Zhao G; Lv Y; Nuerxiati A; Li JA; Wang D; Xu X; Kuang T; Wang X; Lou W; Liu L; Wu W
J Cancer; 2017; 8(16):3362-3370. PubMed ID: 29158809
[No Abstract] [Full Text] [Related]
14. Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma.
Li H; Zhou F; Cao Z; Tang Y; Huang Y; Li Y; Yi B; Yang J; Du P; Zhu D; Zhou J
Front Oncol; 2021; 11():682969. PubMed ID: 34136406
[TBL] [Abstract][Full Text] [Related]
15. A nomogram of preoperative predictors for occult metastasis in patients with PDAC during laparoscopic exploration.
Ge J; Li L; Ma Z; Jiang B; Yuan C; Wang H; Peng Y; Xiu D
Gland Surg; 2021 Jan; 10(1):279-289. PubMed ID: 33633984
[TBL] [Abstract][Full Text] [Related]
16. Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts.
Zhao C; He C; Lu J; Huang X; Chen C; Lin X
Front Oncol; 2022; 12():832038. PubMed ID: 35463346
[TBL] [Abstract][Full Text] [Related]
17. Prognostic effect of CD73 in pancreatic ductal adenocarcinoma for disease-free survival after radical surgery.
Qin D; Wei R; Huang K; Wang R; Ding H; Yao Z; Xi P; Li S
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7805-7817. PubMed ID: 37032378
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Nomogram to Predict Survival in Pancreatic Head Ductal Adenocarcinoma After Pancreaticoduodenectomy.
Peng F; Qin T; Wang M; Wang H; Dang C; Wu CH; Tien YW; Qin R
Front Oncol; 2021; 11():734673. PubMed ID: 34660297
[TBL] [Abstract][Full Text] [Related]
19. Development of Nomograms for Predicting Prognosis of Pancreatic Cancer after Pancreatectomy: A Multicenter Study.
Yoon SJ; Park B; Kwon J; Lim CS; Shin YC; Jung W; Shin SH; Heo JS; Han IW
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740364
[TBL] [Abstract][Full Text] [Related]
20. Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection.
He C; Cai Z; Zhang Y; Lin X
J Oncol; 2021; 2021():3809095. PubMed ID: 34721578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
